In a highly competitive industry, the biopharmaceutical CDMOs that are most likely to succeed are those that are willing to adopt cutting edge technology and invest the necessary time and capital to build out differentiated capabilities. The best CDMOs will move quickly to increase capacity while remaining flexible and agile.
MARKET INSIGHT: Biopharmaceutical CDMOs Analysis
About the Author: Calli Lewis
